News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
850,845 Results
Type
Article (76434)
Company Profile (719)
Press Release (773670)
Multimedia
Podcasts (225)
Webinars (35)
Section
Business (227386)
Career Advice (3751)
Deals (39432)
Drug Delivery (177)
Drug Development (89710)
Employer Resources (207)
FDA (18249)
Job Trends (17230)
News (388362)
Policy (38909)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3052)
Academic (1)
Accelerated approval (56)
Adcomms (40)
Allergies (191)
Alliances (55993)
ALS (233)
Alzheimer's disease (1960)
Antibody-drug conjugate (ADC) (548)
Approvals (18580)
Artificial intelligence (800)
Autoimmune disease (349)
Automation (62)
Bankruptcy (404)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (247)
Biotechnology (437)
Bladder cancer (209)
Brain cancer (84)
Breast cancer (832)
Cancer (6486)
Cardiovascular disease (546)
Career advice (3228)
Career pathing (52)
CAR-T (379)
CDC (76)
Celiac Disease (3)
Cell therapy (1035)
Cervical cancer (53)
Clinical research (77385)
Collaboration (2341)
Company closure (7)
Compensation (1497)
Complete response letters (105)
COVID-19 (3038)
CRISPR (123)
C-suite (1263)
Cystic fibrosis (166)
Data (8565)
Decentralized trials (3)
Denatured (84)
Depression (191)
Dermatology (96)
Diabetes (660)
Diagnostics (7570)
Digital health (63)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (384)
Drug pricing (244)
Drug shortages (39)
Duchenne muscular dystrophy (315)
Earnings (99174)
Editorial (78)
Employer branding (25)
Employer resources (174)
Events (137088)
Executive appointments (1186)
FDA (22265)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (18)
Frontotemporal dementia (36)
Funding (1904)
Gene editing (267)
Generative AI (77)
Gene therapy (831)
GLP-1 (1259)
Government (5505)
Grass and pollen (8)
Guidances (419)
Healthcare (21222)
HIV (91)
Huntington's disease (63)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (114)
Immunology and inflammation (350)
Immuno-oncology (114)
Indications (201)
Infectious disease (3429)
Inflammatory bowel disease (241)
Inflation Reduction Act (17)
Influenza (147)
Intellectual property (312)
Interviews (735)
IPO (17893)
IRA (61)
Job creations (4955)
Job search strategy (2599)
JPM (73)
Kidney cancer (22)
Labor market (120)
Layoffs (680)
Leadership (53)
Legal (9943)
Liver cancer (110)
Longevity (35)
Lung cancer (867)
Lymphoma (460)
Machine learning (63)
Management (66)
Manufacturing (1187)
MASH (221)
Medical device (15235)
Medtech (15384)
Mergers & acquisitions (22814)
Metabolic disorders (1755)
mRNA (262)
Multiple sclerosis (203)
NASH (24)
Neurodegenerative disease (497)
Neuropsychiatric disorders (126)
Neuroscience (3677)
Neurotech (1)
NextGen: Class of 2026 (7663)
Non-profit (5139)
Now hiring (80)
Obesity (844)
Opinion (373)
Ovarian cancer (241)
Pain (280)
Pancreatic cancer (343)
Parkinson's disease (410)
Partnered (36)
Patents (639)
Patient recruitment (734)
Peanut (69)
People (66412)
Pharmaceutical (125)
Pharmacy benefit managers (37)
Phase 1 (23951)
Phase 2 (33764)
Phase 3 (25421)
Pipeline (9581)
Policy (395)
Postmarket research (3246)
Preclinical (10525)
Press Release (72)
Prostate cancer (340)
Psychedelics (68)
Radiopharmaceuticals (369)
Rare diseases (1242)
Real estate (7182)
Recruiting (81)
Regulatory (29493)
Reports (75)
Research institute (2761)
Resumes & cover letters (584)
Rett syndrome (40)
RNA editing (29)
RSV (98)
Schizophrenia (194)
Series A (324)
Series B (232)
Service/supplier (25)
Sickle cell disease (127)
Special edition (32)
Spinal muscular atrophy (189)
Sponsored (55)
Startups (4265)
State (2)
Stomach cancer (21)
Supply chain (142)
Tariffs (104)
The Weekly (138)
Vaccines (1296)
Venture capital (131)
Weight loss (578)
Women's health (135)
Worklife (24)
Date
Today (4)
Last 7 days (770)
Last 30 days (3282)
Last 365 days (32481)
2026 (15429)
2025 (32503)
2024 (37873)
2023 (42563)
2022 (53926)
2021 (58718)
2020 (57660)
2019 (51298)
2018 (39078)
2017 (36783)
2016 (37674)
2015 (43660)
2014 (38253)
2013 (34183)
2012 (36131)
2011 (36206)
2010 (35534)
Location
Africa (1211)
Alabama (102)
Alaska (7)
Arizona (372)
Arkansas (16)
Asia (50634)
Australia (8684)
California (14238)
Canada (3954)
China (1542)
Colorado (610)
Connecticut (631)
Delaware (437)
Europe (115043)
Florida (2114)
Georgia (464)
Hawaii (4)
Idaho (69)
Illinois (1208)
India (101)
Indiana (658)
Iowa (25)
Japan (582)
Kansas (141)
Kentucky (56)
Louisiana (50)
Maine (89)
Maryland (1728)
Massachusetts (10398)
Michigan (408)
Minnesota (793)
Mississippi (7)
Missouri (163)
Montana (37)
Nebraska (30)
Nevada (152)
New Hampshire (91)
New Jersey (3780)
New Mexico (35)
New York (3743)
North Carolina (1912)
North Dakota (11)
Northern California (7079)
Ohio (439)
Oklahoma (26)
Oregon (53)
Pennsylvania (2811)
Puerto Rico (30)
Rhode Island (54)
South America (1576)
South Carolina (88)
South Dakota (2)
Southern California (5594)
Tennessee (224)
Texas (2294)
United States (50823)
Utah (424)
Vermont (1)
Virginia (362)
Washington D.C. (89)
Washington State (1169)
West Virginia (4)
Wisconsin (155)
Wyoming (2)
850,845 Results for "nippon kayaku co ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
AnHeart Therapeutics Announces Exclusive License Agreement With Nippon Kayaku for Taletrectinib in Japan
AnHeart Therapeutics today announced it has entered into an exclusive license agreement with Nippon Kayaku Co., Ltd (“Nippon Kayaku”) to market and distribute AnHeart’s lead investigational therapy, taletrectinib, in Japan.
October 30, 2023
·
6 min read
Press Releases
FreeMind Investments and Daewoong Pharmaceutical Co., Ltd. Invest in General Proximity
May 4, 2026
·
4 min read
Press Releases
Andelyn Biosciences and ENCell Co., Ltd Announce Strategic Partnership to Expand Global Reach of Gene Therapy Manufacturing
April 21, 2026
·
4 min read
Press Releases
Taiwan-Based Towards Buddha Co., Ltd. Showcases Medical-Grade TPU Tubing Injection Solutions at Medtec Japan 2026
April 9, 2026
·
2 min read
Press Releases
Aligos Therapeutics Enters into Exclusive License Deal with Xiamen Amoytop Biotech Co., Ltd. to Develop and Commercialize Pevifoscorvir Sodium in Greater China for Chronic Hepatitis B Virus Infection
April 16, 2026
·
8 min read
Press Releases
Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Bid Price Deficiency
January 19, 2026
·
4 min read
Press Releases
Meiji Holdings Co., Ltd. Highlights that Yogurt Containing Bacteria Metabolite Shows a Tendency Toward Higher Response When Added to Immune Checkpoint Inhibitor Therapy in People Living with Non-small Cell Lung Cancer
April 20, 2026
·
6 min read
Press Releases
Cumulus Neuroscience Enters Japanese Market to Advance Novel Cognitive Biomarkers with New Customer Shionogi & Co., Ltd.
February 10, 2026
·
4 min read
Press Releases
MediKarma Acquires Nanell from Niterra Co., Ltd. to Accelerate Women’s Health Expansion and Value-Based Care Footprint
February 23, 2026
·
3 min read
Business
epitoMAP Inc., Animal Allergy Clinical Laboratories Inc. and Nippon Zenyaku Kogyo Co., Ltd. Enter into License Agreement
epitoMAP Inc. and Animal Allergy Clinical Laboratories Inc. entered into a License Agreement for an antibody pharmaceutical for veterinary use, CRE-DR-B, with Nippon Zenyaku Kogyo Co., Ltd. on November 10, 2023.
November 17, 2023
·
2 min read
1 of 85,085
Next
